These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
650 related articles for article (PubMed ID: 28029304)
1. Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study. Janelsins MC; Heckler CE; Peppone LJ; Kamen C; Mustian KM; Mohile SG; Magnuson A; Kleckner IR; Guido JJ; Young KL; Conlin AK; Weiselberg LR; Mitchell JW; Ambrosone CA; Ahles TA; Morrow GR J Clin Oncol; 2017 Feb; 35(5):506-514. PubMed ID: 28029304 [TBL] [Abstract][Full Text] [Related]
2. Longitudinal Relationship Between Frailty and Cognition in Patients 50 Years and Older with Breast Cancer. Magnuson A; Lei L; Gilmore N; Kleckner AS; Lin FV; Ferguson R; Hurria A; Wittink MN; Esparaz BT; Giguere JK; Misleh J; Bautista J; Mohile SG; Janelsins MC J Am Geriatr Soc; 2019 May; 67(5):928-936. PubMed ID: 31034595 [TBL] [Abstract][Full Text] [Related]
3. Perceived cognitive impairment in people with colorectal cancer who do and do not receive chemotherapy. Dhillon HM; Tannock IF; Pond GR; Renton C; Rourke SB; Vardy JL J Cancer Surviv; 2018 Apr; 12(2):178-185. PubMed ID: 29080061 [TBL] [Abstract][Full Text] [Related]
4. Longitudinal Changes in Cognitive Function in a Nationwide Cohort Study of Patients With Lymphoma Treated With Chemotherapy. Janelsins MC; Mohamed M; Peppone LJ; Magnuson A; Belcher EK; Melnik M; Dakhil S; Geer J; Kamen C; Minasian L; Reagan PM; Mohile SG; Morrow GR; Ahles TA; Heckler CE J Natl Cancer Inst; 2022 Jan; 114(1):47-59. PubMed ID: 34255086 [TBL] [Abstract][Full Text] [Related]
5. Minimal clinically important difference (MCID) for the functional assessment of cancer therapy: cognitive function (FACT-Cog) in breast cancer patients. Cheung YT; Foo YL; Shwe M; Tan YP; Fan G; Yong WS; Madhukumar P; Ooi WS; Chay WY; Dent RA; Ang SF; Lo SK; Yap YS; Ng R; Chan A J Clin Epidemiol; 2014 Jul; 67(7):811-20. PubMed ID: 24656406 [TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy. Jim HS; Phillips KM; Chait S; Faul LA; Popa MA; Lee YH; Hussin MG; Jacobsen PB; Small BJ J Clin Oncol; 2012 Oct; 30(29):3578-87. PubMed ID: 22927526 [TBL] [Abstract][Full Text] [Related]
7. The effect of EEG biofeedback on reducing postcancer cognitive impairment. Alvarez J; Meyer FL; Granoff DL; Lundy A Integr Cancer Ther; 2013 Nov; 12(6):475-87. PubMed ID: 23584550 [TBL] [Abstract][Full Text] [Related]
8. Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. Tchen N; Juffs HG; Downie FP; Yi QL; Hu H; Chemerynsky I; Clemons M; Crump M; Goss PE; Warr D; Tweedale ME; Tannock IF J Clin Oncol; 2003 Nov; 21(22):4175-83. PubMed ID: 14615445 [TBL] [Abstract][Full Text] [Related]
9. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Wefel JS; Lenzi R; Theriault RL; Davis RN; Meyers CA Cancer; 2004 Jun; 100(11):2292-9. PubMed ID: 15160331 [TBL] [Abstract][Full Text] [Related]
10. Evaluating cognitive complaints in breast cancer survivors with the FACT-Cog and quantitative electroencephalography. Van Dyk K; Hunter AM; Ercoli L; Petersen L; Leuchter AF; Ganz PA Breast Cancer Res Treat; 2017 Nov; 166(1):157-166. PubMed ID: 28707203 [TBL] [Abstract][Full Text] [Related]
11. Prechemotherapy Levels of Plasma Dehydroepiandrosterone and Its Sulfated Form as Predictors of Cancer-Related Cognitive Impairment in Patients with Breast Cancer Receiving Chemotherapy. Toh YL; Shariq Mujtaba J; Bansal S; Yeo A; Shwe M; Lau AJ; Chan A Pharmacotherapy; 2019 May; 39(5):553-563. PubMed ID: 30892712 [TBL] [Abstract][Full Text] [Related]
12. Longitudinal Trajectory and Characterization of Cancer-Related Cognitive Impairment in a Nationwide Cohort Study. Janelsins MC; Heckler CE; Peppone LJ; Ahles TA; Mohile SG; Mustian KM; Palesh O; O'Mara AM; Minasian LM; Williams AM; Magnuson A; Geer J; Dakhil SR; Hopkins JO; Morrow GR J Clin Oncol; 2018 Sep; 36(32):JCO2018786624. PubMed ID: 30240328 [TBL] [Abstract][Full Text] [Related]
13. Physical Activity Patterns and Relationships With Cognitive Function in Patients With Breast Cancer Before, During, and After Chemotherapy in a Prospective, Nationwide Study. Salerno EA; Culakova E; Kleckner AS; Heckler CE; Lin PJ; Matthews CE; Conlin A; Weiselberg L; Mitchell J; Mustian KM; Janelsins MC J Clin Oncol; 2021 Oct; 39(29):3283-3292. PubMed ID: 34406822 [TBL] [Abstract][Full Text] [Related]
14. A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy. Lawrence JA; Griffin L; Balcueva EP; Groteluschen DL; Samuel TA; Lesser GJ; Naughton MJ; Case LD; Shaw EG; Rapp SR J Cancer Surviv; 2016 Feb; 10(1):176-84. PubMed ID: 26130292 [TBL] [Abstract][Full Text] [Related]
15. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. Castellon SA; Ganz PA; Bower JE; Petersen L; Abraham L; Greendale GA J Clin Exp Neuropsychol; 2004 Oct; 26(7):955-69. PubMed ID: 15742545 [TBL] [Abstract][Full Text] [Related]
16. Associating persistent self-reported cognitive decline with neurocognitive decline in older breast cancer survivors using machine learning: The Thinking and Living with Cancer study. Van Dyk K; Ahn J; Zhou X; Zhai W; Ahles TA; Bethea TN; Carroll JE; Cohen HJ; Dilawari AA; Graham D; Jacobsen PB; Jim H; McDonald BC; Nakamura ZM; Patel SK; Rentscher KE; Saykin AJ; Small BJ; Mandelblatt JS; Root JC J Geriatr Oncol; 2022 Nov; 13(8):1132-1140. PubMed ID: 36030173 [TBL] [Abstract][Full Text] [Related]
17. Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study. Hermelink K; Untch M; Lux MP; Kreienberg R; Beck T; Bauerfeind I; Münzel K Cancer; 2007 May; 109(9):1905-13. PubMed ID: 17351951 [TBL] [Abstract][Full Text] [Related]
18. Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-study. Schilder CM; Seynaeve C; Linn SC; Boogerd W; Beex LV; Gundy CM; Nortier JW; van de Velde CJ; van Dam FS; Schagen SB Psychooncology; 2012 May; 21(5):479-87. PubMed ID: 21351188 [TBL] [Abstract][Full Text] [Related]
19. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. Fan HG; Houédé-Tchen N; Yi QL; Chemerynsky I; Downie FP; Sabate K; Tannock IF J Clin Oncol; 2005 Nov; 23(31):8025-32. PubMed ID: 16258100 [TBL] [Abstract][Full Text] [Related]
20. Neurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cognition in Breast Cancer Survivors. Kesler SR; Blayney DW JAMA Oncol; 2016 Feb; 2(2):185-92. PubMed ID: 26633037 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]